954271-75-1

Upstream product

• 3306-62-5 2-AMINOBENZENESULFONAMIDE 
• 159622-10-3 (1R,2S)-1-(tert-butoxycarbonylamino)-2-vinylcyclopropanecarboxylic acid 
• 955138-47-3 [2-[((1R,2S)-1-tert-Butoxycarbonylamino-2-vinyl-cyclopropanecarbonyl)-sulfamoyl]-phenyl]-carbamic acid 2-trimethylsilanyl-ethyl ester 
• 665-46-3 tetraethylammonium fluoride 

Downstream Products

• 1051391-38-8 8-{2-[((1R,2S)-1-tert-butoxycarbonylamino-2-vinyl-cyclopropanecarbonyl)-sulfamoyl]-phenylcarbamoyl}-octanoic acid methyl ester 
• 1051391-83-3 9-{2-[((1R,2S)-1-tert-butoxycarbonylamino-2-vinyl-cyclopropanecarbonyl)-sulfamoyl]-phenylamino}-nonanoic acid methyl ester 
• 1013925-45-5 [(1R,2S)-1-(2-Hept-6-enoylamino-benzenesulfonylaminocarbonyl)-2-vinylcyclopropyl]-carbamic acid tert-butyl ester 
• 1013925-54-6 [(1R,2S)-1-(2-Hept-6-enylamino-benzenesulfonylaminocarbonyl)-2-vinyl-cyclopropyl]-carbamic acid tert-butyl ester 
• 1051391-84-4 9-{2-[((1R,2S)-1-amino-2-vinyl-cyclopropanecarbonyl)-sulfamoyl]-phenylamino}-nonanoic acid methyl ester 
• 1051391-40-2 8-{2-[((1R,2S)-1-amino-2-vinyl-cyclopropanecarbonyl)-sulfamoyl]-phenylcarbamoyl}-octanoic acid methyl ester hydrochloride 
• 1051388-88-5 (8S,10R)-10-(7-methoxy-2-phenyl-quinolin-4-yloxy)-5-[(1R,2S)-1-carbonylamino-2-vinyl-cyclopropyl]-2,2-dioxo-2λ*6*-thia-3,6,12,22-tetraaza-tricyclo[21.4.0.0*8,12*]heptacosa-1(27),23,25-triene-4,7,13,21-tetraone 
• 1051391-37-7 8-{2-[((1R,2S)-1-{[(2S,4R)-4-(7-methoxy-2-phenyl-quinolin-4-yloxy)-pyrrolidine-2-carbonyl]-amino}-2-vinyl-cyclopropanecarbonyl)-sulfamoyl]-phenylcarbamoyl}-octanoic acid 
• 1051391-41-3 (2S,4R)-2-{(1R,2S)-1-[2-(8-methoxycarbonyl-octanoylamino)-benzenesulfonylaminocarbonyl]-2-vinyl-cyclopropylcarbamoyl}-4-(7-methoxy-2-phenyl-quinolin-4-yloxy)-pyrrolidine-1-carboxylic acid tert-butyl ester 

Relevant academic research and scientific papers

ORGANIC COMPOUNDS AND THEIR USES

The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of human diseases.

MACROCYCLIC COMPOUNDS AS HCV NS3 PROTEASE INHIBITORS

The present application describes macrocyclic compounds of formula (I) with NS3 protease inhibitory activity for treating hepatitis C virus infection.